首页> 外文期刊>Brazilian Journal of Medical and Biological Research >Accuracy of dose planning for prostate radiotherapy in the presence of metallic implants evaluated by electron spin resonance dosimetry
【24h】

Accuracy of dose planning for prostate radiotherapy in the presence of metallic implants evaluated by electron spin resonance dosimetry

机译:通过电子自旋共振剂量法评估存在金属植入物时前列腺放射治疗剂量规划的准确性

获取原文
           

摘要

Radiotherapy is one of the main approaches to cure prostate cancer, and its success depends on the accuracy of dose planning. A complicating factor is the presence of a metallic prosthesis in the femur and pelvis, which is becoming more common in elderly populations. The goal of this work was to perform dose measurements to check the accuracy of radiotherapy treatment planning under these complicated conditions. To accomplish this, a scale phantom of an adult pelvic region was used with alanine dosimeters inserted in the prostate region. This phantom was irradiated according to the planned treatment under the following three conditions: with two metallic prostheses in the region of the femur head, with only one prosthesis, and without any prostheses. The combined relative standard uncertainty of dose measurement by electron spin resonance (ESR)/alanine was 5.05%, whereas the combined relative standard uncertainty of the applied dose was 3.35%, resulting in a combined relative standard uncertainty of the whole process of 6.06%. The ESR dosimetry indicated that there was no difference (P>0.05, ANOVA) in dosage between the planned dose and treatments. The results are in the range of the planned dose, within the combined relative uncertainty, demonstrating that the treatment-planning system compensates for the effects caused by the presence of femur and hip metal prostheses.
机译:放射疗法是治疗前列腺癌的主要方法之一,其成功取决于剂量规划的准确性。一个复杂的因素是在股骨和骨盆中存在金属假体,这种假体在老年人口中变得越来越普遍。这项工作的目的是进行剂量测量,以检查在这些复杂条件下放射治疗计划的准确性。为了实现这一点,使用成人骨盆区域的比例模型,并在前列腺区域插入了丙氨酸剂量计。根据计划的治疗方法,在以下三种情况下对该体模进行辐照:在股骨头区域中使用两个金属假体,仅使用一个假体,并且不使用任何假体。通过电子自旋共振(ESR)/丙氨酸进行剂量测量的组合相对标准不确定度为5.05%,而所施加剂量的组合相对标准不确定度为3.35%,导致整个过程的组合相对标准不确定度为6.06%。 ESR剂量测定表明,计划剂量和治疗之间的剂量没有差异(P> 0.05,ANOVA)。结果在组合相对不确定性范围内的计划剂量范围内,表明治疗计划系统补偿了股骨和髋关节金属假体的存在所造成的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号